InvestorsHub Logo
Followers 10
Posts 1672
Boards Moderated 1
Alias Born 11/13/2018

Re: None

Tuesday, 12/14/2021 9:09:29 PM

Tuesday, December 14, 2021 9:09:29 PM

Post# of 70340
https://sec.report/Document/0001279569-21-001800/

EDMONTON, AB, Dec. 14, 2021 /CNW/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB) ("Aurora"), the Canadian company defining the future of cannabinoids worldwide, together with 22nd Century Group, Inc. (NASDAQ: XXII) ("22nd Century") announced today a three-way non-exclusive agreement to license biosynthesis intellectual property to Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) ("Cronos Group"), intended to assist in the advancement of research and development on the biosynthesis of cannabinoids.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ACB News